Kay Tait
Chair
AstraZeneca
... Operations team. Kay is involved in all aspects of transaction negotiation and execution across multiple therapy areas. Prior to that, Kay worked as a Business Development Director covering both search and evaluation, as well as transaction, for AstraZeneca’s Oncology business.
Kay has a wealth of business development experience ranging from in and out-licensing, acquisition and partnering activities from early stage discovery through to on-market commercial opportunities. Before her business development career, Kay worked in R&D at AstraZeneca. She also holds a Ph.D. in molecular biology and a first class honours degree both from the University Manchester.
[More]